Posts by Admin BioAlps

Lunaphore closes its Series C funding   On 6 February 2020, the EPFL spin-off, Lunaphore, founded in 2014, announced the completion of its Series C funding of CHF 23 million, adding to its existing capital of CHF 11.3 million.   The startup provides high speed qualitative automated tools which use immunohistochemistry to deliver precise diagnostics. Lunaphore…

New centre of excellence in the canton of Vaud | GE Healthcare Life Sciences   GE Healthcare Life Sciences will build a new manufacturing site in the Signy Park in Gens, in the canton of Vaud, by 2022.   The 7’360 square meter facility will support the US-based multinational to meet increasing global demand for…

Creation of a European Consortium | ORGANTRANS   On 4 February 2020, the CSEM announced the creation of  the European project ORGANTRANS. The project will be financed by the H2020 programme and coordinated by the CSEM. The eight partners taking part in the project aim to develop a disruptive solution able to create organ structure through 3D tissue…

The Swiss Venture Capital Report 2020 is out | Encouraging results for biotech and healthcare IT sectors   The 8th edition of the Swiss Venture Capital Report (SVCR), published by startupticker.ch and the investor association SECA, depicts changes in the Swiss innovation landscape.   After a decrease in investment in Swiss biotech startups in 2018,…

European Innovation Council (EIC) Accelerator | Novostia part of the 9 selected Swiss startups   The European Commission selected 75 startups and SMEs out of 1852 applicants from the European Union to take part in the EIC Accelerator pilot. Novostia, the Neuchâtel-based medtech startup, was selected among the Swiss projects.   €278 million will be allocated to…

GeNeuro secures investment to further clinical trials   GeNeuro, the Geneva-based biopharmaceutical company, announced on 31 January 2020 the securing of a €17.5 international private placement. This investment will support the company in competing its clinical trial of temelimab in multiple sclerosis patients, as well as advance the preclinical programme for ALS and more. Read…

Endotelix Diagnostics Sàrl | Solution provider for Antiphospholipid Syndrome   In 2020, VentureKick allocated CHF 5 million to 80 Swiss startup projects.   The University of Geneva spin-off, Endotelix Diagnostics, which specialises in point-of-care diagnostics for autoimmune diseases, won the Stage 3 prize of CHF 150’000.   Antiphospholipid Syndrome (APS) is one of the main causes of strokes in…

Merck Biotech Development Center | New Facility in Switzerland   On 27 January 2020, Merck announced a €250 million investment to build a new research and manufacturing facility in Corsier-sur-Vevey, in the canton of Vaud.   The investment, to be made between 2019 and 2022, will help secure the needed facility to develop the biotech…

Another milestone for Nanolive, as the company moves to new offices   In 2013, Nanolive started its adventure in a small office space. In 2020, the company will set up its new 1’100 m2 quarters in Tolochenaz.   The Grand Opening will take place on Friday 14th February as of 4:30PM.   You can take part…

Join SILAB and take part in Innosuisse’s NTN Innovation Booster programme Imagine and develop the healthcare of tomorrow   Innovation to tackle healthcare challenges Innovation in healthcare is key to tackle the challenges faced by the healthcare system in a deeply changing societal landscape.It becomes increasingly recognized that innovation must be centred around the patient…